Suppr超能文献

治疗体验和自我管理患者报告衡量指标(PETS vs. 2.0)的已知群组有效性和对变化的反应性:治疗负担。

Known-groups validity and responsiveness to change of the Patient Experience with Treatment and Self-management (PETS vs. 2.0): a patient-reported measure of treatment burden.

机构信息

Department of Health Sciences Research, Mayo Clinic, 200 First St SW, Harwick Building, Rochester, MN, 55905, USA.

Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, USA.

出版信息

Qual Life Res. 2020 Nov;29(11):3143-3154. doi: 10.1007/s11136-020-02546-x. Epub 2020 Jun 10.

Abstract

PURPOSE

The purpose of this study was to test the known-groups validity and responsiveness to change of the Patient Experience with Treatment and Self-management (PETS, vs. 2.0), a measure of treatment burden.

METHODS

The PETS and other standard measures were mailed at baseline and 12-month follow-up to adults living with multiple chronic conditions in southeast Minnesota (USA). A sample of 365 people (mean age = 62.1 years) completed both surveys. Baseline, 12-month, and changes in PETS burden scores were examined. Clinical anchors used to test validity included number of diagnoses (2-4 vs. 5+), mental health diagnosis (yes/no), medication adherence and health literacy (suboptimal/optimal), and changes in self-efficacy, global physical, and global mental health (worsening/improving). Independent-samples t-tests were used to compare scores.

RESULTS

PETS scales showed good internal consistency (αs ≥ 0.80). There were few differences across number of diagnoses, but having a mental health diagnosis was associated with higher baseline PETS burden scores (Ps < .05). Suboptimal medication adherence and health literacy over time were associated with worse 12-month PETS burden scores (Ps < .05). Compared with improvements, declines over time in self-efficacy, global physical health, and global mental health were each associated with worsening change scores on PETS impact summary, medical expenses, and bother due to medication reliance and medication side effects (Ps < .05).

CONCLUSION

Among multi-morbid adults, the PETS demonstrated evidence of known-groups validity and responsiveness to change across both objective (e.g., mental health diagnoses) and subjective anchors (e.g., changes in self-efficacy, global physical, and global mental health).

摘要

目的

本研究旨在检验治疗负担评估工具——患者治疗体验和自我管理量表(PETS,版本 2.0)的已知群组有效性和对变化的反应能力。

方法

在明尼苏达州东南部(美国)患有多种慢性疾病的成年人中,通过邮件发送 PETS 量表和其他标准量表进行基线和 12 个月随访。365 名(平均年龄 62.1 岁)完成了两次调查的人被纳入样本。检验了基线、12 个月和 PETS 负担评分的变化。用于检验有效性的临床锚点包括诊断数量(2-4 个与 5 个以上)、心理健康诊断(是/否)、药物依从性和健康素养(欠佳/良好)以及自我效能、总体身体和总体心理健康的变化(恶化/改善)。使用独立样本 t 检验比较得分。

结果

PETS 量表具有良好的内部一致性(α 值≥0.80)。诊断数量之间的差异不大,但存在心理健康诊断与较高的基线 PETS 负担评分相关(P<0.05)。药物依从性和健康素养欠佳随时间变化与较差的 12 个月 PETS 负担评分相关(P<0.05)。与改善相比,自我效能、总体身体健康和总体心理健康随时间下降与 PETS 影响摘要、医疗费用以及因药物依赖和药物副作用引起的烦恼的变化评分恶化相关(P<0.05)。

结论

在患有多种疾病的成年人中,PETS 表现出已知群组有效性和对变化的反应能力的证据,包括客观(如心理健康诊断)和主观锚点(如自我效能、总体身体和总体心理健康的变化)。

相似文献

6
Development and validation of the Multimorbidity Treatment Burden Questionnaire (MTBQ).
BMJ Open. 2018 Apr 12;8(4):e019413. doi: 10.1136/bmjopen-2017-019413.
7
Treatment burden for people experiencing homelessness with a recent non-fatal overdose: a questionnaire study.
Br J Gen Pract. 2023 Sep 28;73(735):e728-e734. doi: 10.3399/BJGP.2022.0587. Print 2023 Oct.
8
Treatment Burden in People with Hypertension is Correlated with Patient Experience with Self-Management.
J Am Board Fam Med. 2021 Nov-Dec;34(6):1243-1245. doi: 10.3122/jabfm.2021.06.210191.

引用本文的文献

2
Deriving severity thresholds of treatment burden for the patient experience with treatment and self-management (PETS).
J Multimorb Comorb. 2025 Jun 23;15:26335565251350923. doi: 10.1177/26335565251350923. eCollection 2025 Jan-Dec.
3
Treatment burden in multimorbidity: an integrative review.
BMC Prim Care. 2024 Sep 28;25(1):352. doi: 10.1186/s12875-024-02586-z.
4
Trajectories of Treatment Burden Among Primary Care Patients with Long-Term Conditions in Southern China: A Latent Class Growth Analysis.
Risk Manag Healthc Policy. 2024 Aug 22;17:2009-2021. doi: 10.2147/RMHP.S464434. eCollection 2024.
5
Development of a digital platform for nursing monitoring of patients with chronic kidney failure.
Int Urol Nephrol. 2025 Jan;57(1):285-294. doi: 10.1007/s11255-024-04186-3. Epub 2024 Aug 24.
9
A Single-Center Retrospective Evaluation of Decision-Making and Factors Motivating Hand Transplant Candidates.
Prog Transplant. 2023 Sep;33(3):216-222. doi: 10.1177/15269248231189863. Epub 2023 Aug 2.
10
Treatment burden for people experiencing homelessness with a recent non-fatal overdose: a questionnaire study.
Br J Gen Pract. 2023 Sep 28;73(735):e728-e734. doi: 10.3399/BJGP.2022.0587. Print 2023 Oct.

本文引用的文献

1
Social Networks of Self-care and Perceived Treatment Burden Among Patients on In-Center Hemodialysis.
Kidney Med. 2019 May 10;1(3):97-103. doi: 10.1016/j.xkme.2019.04.001. eCollection 2019 May-Jun.
3
Treatment burden should be included in clinical practice guidelines.
BMJ. 2018 Oct 12;363:k4065. doi: 10.1136/bmj.k4065.
4
Reserve-building activities attenuate treatment burden in chronic illness: The mediating role of appraisal and social support.
Health Psychol Open. 2018 May 14;5(1):2055102918773440. doi: 10.1177/2055102918773440. eCollection 2018 Jan-Jun.
5
Development and validation of the Multimorbidity Treatment Burden Questionnaire (MTBQ).
BMJ Open. 2018 Apr 12;8(4):e019413. doi: 10.1136/bmjopen-2017-019413.
8
Multi-morbidity: A patient perspective on navigating the health care system and everyday life.
Chronic Illn. 2018 Dec;14(4):271-282. doi: 10.1177/1742395317731607. Epub 2017 Sep 15.
9
The Perceived Medical Condition Self-Management Scale can be applied to patients with chronic kidney disease.
Kidney Int. 2017 Oct;92(4):972-978. doi: 10.1016/j.kint.2017.03.018. Epub 2017 May 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验